Share
Other content recommended for you
- New diagnostic criteria for Alzheimer's disease and mild cognitive impairment for the practical neurologist
- Retinal imaging in Alzheimer’s disease
- On the personal utility of Alzheimer’s disease-related biomarker testing in the research context
- Amyloid PET imaging in clinical practice
- Mild cognitive impairment in primary care: a clinical review
- Imaging of neuroinflammation in dementia: a review
- How many patients are eligible for disease-modifying treatment in Alzheimer’s disease? A French national observational study over 5 years
- Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia
- Pupillary light reaction in preclinical Alzheimer’s disease subjects compared with normal ageing controls
- Protocol for a double-blind placebo-controlled randomised controlled trial assessing the impact of oral semaglutide in amyloid positivity (ISAP) in community dwelling UK adults